ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Bioinformatics"

  • Abstract Number: 1607 • ACR Convergence 2022

    Machine Learning Identifies Biomarker of Non-Response to Methotrexate in Rheumatoid Arthritis

    Vincent Bouget1, Julien Duquesne1, Paul-Henry Cournède2, Bruno Fautrel3, Francis Guillemin4, Pascal de Jong5, Judith Heutz6, Marloes Verstappen7, Annette van der Helm-van Mil8, Xavier Mariette9 and Samuel Bitoun10, 1Scienta Lab, Paris, France, 2Paris-Saclay University - CentraleSupelec, Paris, France, 3Sorbonne University Paris, France and Pierre Louis Institute of Epidemiology and Public Health, Paris, France, Paris, France, 4Université de Lorraine, APEMAC, Vandoeuvre-les-nancy, France, 5ErasmusMC, Hendrik Ido Ambacht, Netherlands, 6Erasmus Medical Center, Rotterdam, Netherlands, 7Leiden University Medical Center, Leiden, Netherlands, 8Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands, 9Paris-Saclay University, Rueil Malmaison, Ile-de-France, France, 10Paris-Saclay University, Paris, France

    Background/Purpose: Methotrexate (MTX) is the first line treatment for rheumatoid arthritis (RA). Unfortunately, 30% to 40% of RA patients do not respond to MTX with…
  • Abstract Number: 0564 • ACR Convergence 2022

    Identifying Shared Genetic Architecture Between RA and Other Conditions: A Phenome-Wide Association Study

    Harrison Zhang1, Gregory McDermott2, Thany Seyok2, Sicong Huang2, Kumar Dahal2, Sehi L'Yi1, Clara Lea-Bonzel1, Jacklyn Stratton2, Dana Weisenfeld2, Tianrun Cai2, Paul Monach3, Jing Cui2, Chuan Hong4, Tianxi Cai5 and Katherine Liao2, 1Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3VA Boston Healthcare System, Boston, MA, 4Duke University, Durham, NC, 5Harvard TH Chan School of Public Health, Boston, MA

    Background/Purpose: RA shares individual risk alleles with other autoimmune conditions such as type 1 diabetes and celiac disease. However, there are limited studies examining the…
  • Abstract Number: 1120 • ACR Convergence 2022

    Transcriptome-Wide Association Study of Sjögren’s Disease Risk Alleles Identifies Novel Genes with Altered Expression in Minor Salivary Gland and Other Tissues

    Marcin Radziszewski1, Mandi Wiley1, Bhuwan Khatri1, Kandice Tessneer1, Astrid Rasmussen1, Professor Simon Bowman2, Lida Radfar3, Roald Omdal4, Marie Wahren-Herlenius5, Blake Warner6, Torsten Witte7, Roland Jonsson8, Maureen Rischmueller9, Patrick Gaffney1, Judith James1, Lars Ronnblom10, R. Hal Scofield3, Xavier Mariette11, Marta Alarcon-Riquelme12, Fai Ng13, Gunnel Nordmark10, Umesh Deshmukh1, A. Darise Farris1 and Christopher Lessard1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University Hospitals Birmingham, Birmingham, United Kingdom, 3University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Stavanger University, Stavanger, Norway, 5Karolinska Institutet, Stockholm, Sweden, 6National Institutes of Health, Bethesda, MD, 7MH-Hannover, Hannover, Germany, 8University of Bergen, Bergen, Norway, 9RheumatologySA, Adelaide, Australia, 10Uppsala University, Uppsala, Sweden, 11Paris-Saclay University, Rueil Malmaison, Ile-de-France, France, 12Center for Genomics and Oncological Research (GENYO), Granada, Spain, 13Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

    Background/Purpose: Sjögren's disease (SjD) is an autoimmune disease characterized by reduced function of exocrine glands, but also has systemic manifestations affecting multiple organs, including abnormal…
  • Abstract Number: 1625 • ACR Convergence 2022

    Single Cell and Spatial Transcriptomics Identifies Pathogenic Drivers of Sjogren’s Disease in Humans

    Blake Warner1, Thomas Pranzatelli2, Paola Perez2, Daniel Martin2, Shyh-Ing Jang2, Kalie Dominick2, Eiko Yamada2, Kevin Byrd3, Quinn Easter4, A. Darise Farris5, Christopher Lessard5, Amanda Oliver6, Raquel Bartolome-Casado6, Zohreh Khavandgar1, Sarthak Gupta7, Sarah Teichmann6, Alan Baer8 and John Chiorini2, 1National Institutes of Health, Bethesda, MD, 2NIDCR, Bethesda, MD, 3American Dental Association, Scientific Research Institute, Gaithersburg, MD, 4American Dental Association, Gaithersburg, MD, 5Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Wellcome Sanger Institute, Cambridgeshire, United Kingdom, 7National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 8Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Sjogren's Disease(SjD) is a systemic autoimmune disease characterized by exocrine dysfunction. The pathogenesis is incompletely understood, but involves gene-environment interactions leading to infiltration of…
  • Abstract Number: 0973 • ACR Convergence 2021

    Modeling of Clinical Phenotypes in SLE Based on Platelet Transcriptomic Analysis and FCGR2a Biallelic Variants

    MacIntosh Cornwell1, Hanane EL Bannoudi2, Elliot Luttrell-Williams1, Khrystyna Myndzar1, Alexis Engel3, Peter Izmirly4, H. Michael Belmont5, Robert Clancy6, Jeffrey Berger1, Kelly Ruggles1 and Jill Buyon6, 1New York University, New York, NY, 2NYU Langone Health, New York, NY, 3NYU Langone Health, New Yok, NY, 4New York University School of Medicine, New York, NY, 5NYU School of Medicine, New York, NY, 6NYU Grossman School of Medicine, New York, NY

    Background/Purpose: The clinical heterogeneity of SLE with its complex pathogenesis remains challenging as we strive to provide optimal management. The contribution of platelets to endovascular…
  • Abstract Number: 1011 • ACR Convergence 2021

    Validation of Bioinformatics Pipeline to Detect NEMO-Deleted Exon 5 Autoinflammatory Syndrome (NEMO-NDAS) and Preliminary Clinical and Immunologic Characterization

    Adriana Almeida de Jesus1, Bin Lin2, Eric Karlins3, Dana Kahle4, Andre Rastegar2, Jacob Mitchell2, Sofia Torreggiani2, Farzana Bhuyan2, Sara Alehashemi5, Kader Cetin Gedik6, Kat Uss2, Chyi-Chia Lee7, Hyesun Kuehn8, Sergio Rosenzweig8, Katherine Calvo8, Magdalena Walkiewicz9, Justin Lack10, Eric Hanson11, Amer Khojah12, Eveline Wu13, Christiaan Scott14, Timothy Ronan Leahy15, Emma MacDermott15, Orla Kileen15, Thaschawee Arkachaisri16, Zoran Gucev17, Kathryn Cook18, Vafa Mammadova19, Gulnara Nasrullayeva19, Scott Canna20, Douglas Kuhns21, Clifton Dalgard22, Timothy Moran23, Andrew Oler3 and Raphaela Goldbach-Mansky24, 1TADS/NIAID/NIH, Silver Spring, MD, 2TADS/NIAID/NIH, Bethesda, MD, 3BCBB/NIAID/NIH, Bethesda, MD, 4National Institutes of Health, Chevy Chase, MD, 5TADS/NIAID/NIH, Clarksville, MD, 6Translational Autoinflammatory Diseases Section (TADS)/NIAID/NIH, Bethesda, MD, 7NCI/NIH, Bethesda, MD, 8CC/DLM/NIH, Bethesda, MD, 9CSI/NIAID/NIH, Bethesda, MD, 10NCBR/NIAID/NIH, Bethesda, MD, 11Indiana University School of Medicine, Indianapolis, IN, 12Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 13UNC Chapel Hill, Chapel Hill, NC, 14Paediatric Rheumatology, University of Cape Town, Cape Town, South Africa, 15Children’s Health Ireland (CHI) at Crumlin, Dublin, Ireland, 16KK Women's and Children's Hospital, SingHealth, Singapore, Singapore, 17University Children's Hospital, Medical Faculty Skopje, Skopje, Macedonia, 18Akron Childrens Hospital, Copley, OH, 19Azerbaijan Medical University, Baku, Azerbaijan, 20Children's Hospital of Philadelphia, Philadelphia, PA, 21Frederick National Laboratory for Cancer Research/NIH, Frederick, MD, 22TAGC/USUHS, Bethesda, MD, 23University of North Carolina School of Medicine, Chapel Hill, NC, 24NIH/NIAID, Potomac, MD

    Background/Purpose: Splice site variants in IKBKG that lead to exon 5 deletion cause NEMO-deleted exon 5 autoinflammatory syndrome (NEMO-NDAS). NEMO-NDAS clinically mimics the interferonopathy chronic…
  • Abstract Number: 1384 • ACR Convergence 2021

    A Genomic Meta-Analysis of Clinical Variables and Association with Intrinsic Molecular Subsets in Systemic Sclerosis

    Jennifer Franks1, Diana Toledo1, Viktor Martyanov1, Yue Wang2, Suiyuan Huang3, Tammara Wood1, Cathie Spino3, Robyn Domsic4, Monique Hinchcliff5, Dinesh Khanna3 and Michael Whitfield6, 1Geisel School of Medicine at Dartmouth, Hanover, NH, 2Geisel School of Medicine at Dartmouth, West Lebanon, NH, 3University of Michigan, Ann Arbor, MI, 4University of Pittsburgh, Pittsburgh, PA, 5Yale School of Medicine, Westport, CT, 6Geisel School of Medicine, Lebanon, NH

    Background/Purpose: Four intrinsic molecular subsets (Inflammatory, Fibroproliferative, Limited, Normal-like) have been identified in systemic sclerosis (SSc) that may have different clinical associations. To test this…
  • Abstract Number: 1480 • ACR Convergence 2021

    LncRNA XIST Alters the Balance of Peripheral Blood Immune Cells in Systemic Lupus Erythematosus by Regulating the miR-17-92/OFLM4 and CEACAM8 Axis

    Qi Cheng, Mo Chen, xin Chen, peiyu zhang, huaxiang wu and yan du, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China (People's Republic)

    Background/Purpose: X-inactive-specific transcript (XIST) has been shown to silence linked genes on the X chromosome that may be related to the pathogenesis of systemic lupus…
  • Abstract Number: 1665 • ACR Convergence 2021

    Physical Activity Moderates Inflammatory Gene Expression in Rheumatoid Arthritis

    Sarah Patterson1, Shenghuan Sun2, Dmitry Rychkov2, Alexandra Tsitsiklis2, Paula Hayakawa Serpa2, Patricia Katz2, Charles Langelier2 and Marina Sirota2, 1University of California San Francisco, Pacifica, CA, 2University of California San Francisco, San Francisco, CA

    Background/Purpose: Prior studies show an independent association between greater physical activity and lower inflammatory markers among adults in the general population, but the impact of…
  • Abstract Number: 0051 • ACR Convergence 2021

    Identification of Biomarkers and Deregulated Pathways in Psoriatic Arthritis Through Proteomic Analysis of Synovial Fluid

    Jacqueline Lai1, Sara Rahmati2, Raam Sivakumar2, Katerina Oikonomopoulou3, Fatima Abji4 and Vinod Chandran5, 1McMaster University, Hamilton, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Krembil Research Institute, Toronto, ON, Canada, 4University of Toronto, University Health Network, Toronto, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Psoriatic arthritis (PsA) is an inflammatory arthritis that currently lacks diagnostic biomarkers. We hypothesized that there are differences in the protein intensities in the…
  • Abstract Number: 0258 • ACR Convergence 2021

    Developing Electronic Health Record Algorithms That Accurately Identify Patients with Juvenile Idiopathic Arthritis

    Hannah Peterson1, April Barnado2 and Anna Patrick2, 1Lipscomb University College of Pharmacy, Nashville, TN, 2Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Electronic Health Records (EHRs) store nearly all clinical data in one central location providing increased accessibility, accuracy, and security. At our institution, the Synthetic…
  • Abstract Number: 0331 • ACR Convergence 2021

    Urinary MicroRNAs as Systemic Lupus Erythematosus Biomarkers and Its Potential for Accurate Assessment of Disease Severity

    Hiroki Yamaguchi1, Yoriko Ando1, Mika Mizunuma1, Masamichi Inami2, Kenichi Suzumura2 and Yuki Ichikawa1, 1Craif Inc., Nagoya, Japan, 2Analysis & Pharmacokinetics Research Labs., Astellas Pharma Inc., Tsukuba, Japan

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by autoantibody production, immune complex deposition, and heterogeneous clinical manifestations affecting many organs, including…
  • Abstract Number: 0341 • ACR Convergence 2021

    Addition of Narrative Text Abstraction to ICD-Based Abstraction Significantly Improves Identification of Lupus Nephritis in Real-World Data

    Meghan Tierney and Chris Rowe, PicnicHealth, San Francisco, CA

    Background/Purpose: Lupus nephritis (LN) is often underrecognized and difficult to identify retrospectively, presenting challenges for clinicians and researchers hoping to explore this condition using real-world…
  • Abstract Number: 0502 • ACR Convergence 2021

    Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Non-inflammatory Aortic Aneurysms

    Benjamin Hur1, Matthew Koster1, Jin Sung Jang1, Kenneth Warrington2 and Jaeyun Sung1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, Minnesota

    Background/Purpose: Non-infectious aortitis may be a manifestation of systemic large vessel vasculitis such as giant cell arteritis (GCA) or may be a form of single…
  • Abstract Number: 0523 • ACR Convergence 2021

    Transcriptional Subsetting of SLE Patient Cohorts Based on Metabolic Pathway Activity

    Diogo Camacho, Jennifer Swantek, Keng Soh, Jurre Kamphorst, Vivek Kaimal, John Monroe and Edward Driggers, Rheos Medicines, Inc, Cambridge, MA

    Background/Purpose: Systemic lupus erythematosus is a highly complex, heterogeneous, autoimmune disorder, with diverse clinical presentation and innate and adaptive immune system involvement. There is a…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 21
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology